Genericlicensing.com, the business development division of ICE Pharma Group, says it is starting a revolution for business development within the generic pharmaceutical industry by providing free access to the world's first searchable database of generic dossiers available for licensing, both approved and in development.
Genericlicensing.com heralds a new era when all companies can benefit from a directory of key data and have immediate access to a global product pipeline. As a premier source of key decision making information, it will also ensure opportunities are now available to a much wider audience for example smaller companies and those in emerging economies such as Eastern Europe and Latin America, the publisher says.
The directory lists over 6,500 products from over 120 companies. It claims to cover established companies and emerging businesses, over 600 registered buyers online from over 100 countries.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze